secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2023-03-09T23:59:59+00:00
Accession:  0001411690-23-000008
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionano Q4 revenue $8.2M (+30% YoY); FY2022 rev $27.8M (+55%)
-------------------------------------------------------------

- Q4 revenue $8.2M, up 30% from Q4 2021; FY2022 revenue $27.8M, up 55% from FY2021.
- Installed base of Saphyr systems reached 240 at YE 2022, a 46% increase over 2021.
- Acquired Purigen Biosystems to accelerate OGM adoption; deal value not disclosed.
- Achieved all 2022 ELEVATE! milestones; next-gen OGM system commercial launch planned H1 2023.
- 2023 revenue outlook provided but specific guidance range not included in this excerpt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000141169023000008/0001411690-23-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000141169023000008/bngo-20230309.htm
  HTML page:      https://secwatch.observer/filing/0001411690-23-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer